ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

SANF Sanofi

0.00
0.00 (0.00%)
Share Name Share Symbol Market Stock Type
Sanofi SANF Italy Ordinary Share
  Price Change Price Change % Share Price Last Trade
0.00 0.00% -
Open Price Low Price High Price Close Price Previous Close
more quote information »

Recent News

Date Time Source Heading
5/02/202400:00GLOBEPress Release: Beyfortus real-world evidence published in..
4/30/202411:00GLOBEPress Release: Annual General Meeting of April 30, 2024
4/25/202400:30GLOBECommuniqué de presse : Sanofi réitère ses objectifs..
4/23/202400:00GLOBEPress Release: Rilzabrutinib LUNA 3 phase 3 study met..
4/17/202400:00GLOBECommuniqué de presse : De nouveaux résultats de phase II à..
4/12/202413:05GLOBESanofi: Information concerning the total number of voting..
4/08/202411:00GLOBESanofi - AGM 30.04.2024 - Availability of Preparatory..
3/22/202401:30GLOBEPress Release: Availability of the Q1 2024 Memorandum for..
3/15/202414:04GLOBESanofi: Informations relatives au nombre de droits de vote..
3/11/202401:00GLOBECommuniqué de presse : De nouveaux résultats de phase II..
2/24/202408:51GLOBEPress Release: Phase 2 results demonstrate rilzabrutinib..
2/23/202411:45GLOBEPress Release: Filing of the 2023 U.S. Form 20-F and French..
2/23/202400:00GLOBEPress Release: Dupixent® sBLA accepted for FDA Priority..
2/22/202412:02GLOBECommuniqué de presse : Le Conseil d’administration de Sanofi..
2/20/202416:40GLOBESanofi: Informations relatives au nombre de droits de vote..
2/16/202400:00GLOBECommuniqué de presse : Le Japon est le premier pays dans le..
2/15/202407:00GLOBECommuniqué de presse : Des données de phase II publiées dans..
2/05/202401:00GLOBEPress Release: Peer support, flexible work arrangements,..
2/01/202400:30GLOBEPress Release: Sanofi Delivers Solid Sales and Business EPS..
1/25/202413:30GLOBEPress Release: Dupixent® FDA approved as first and only..
1/23/202400:30GLOBECommuniqué de presse : Sanofi va acquérir Inhibrx, Inc. et..
1/17/202415:57GLOBESanofi: Informations relatives au nombre de droits de vote..
1/09/202400:30GLOBECommuniqué de presse : Brian Foard est nommé Responsable de..
12/21/202300:30GLOBEPress Release: Sanofi announces end of program evaluating..
12/18/202314:59GLOBESanofi: Information concerning the total number of voting..
12/15/202300:30GLOBEPress Release: Availability of the Q4 2023 Memorandum for..
12/15/202300:00GLOBECommuniqué de presse : L’EMA a rendu un avis favorable pour..
12/11/202315:08GLOBECommuniqué de presse : Déclaration au sujet de la..
12/10/202318:30GLOBECP : Sarclisa® (isatuximab) plus KRd améliore..
12/07/202300:35GLOBECP : L’essai de phase III consacré au Sarclisa® (isatuximab)..
12/06/202320:30GLOBEPress Release: Sanofi Pipeline Transformation to Accelerate..
11/27/202300:30GLOBECommuniqué de presse : Dupixent® a permis de réduire..
11/23/202311:00GLOBESanofi: Information concerning the total number of voting..
10/27/202300:31GLOBECommuniqué de presse : Un troisième trimestre solide, marqué..
10/27/202300:30GLOBECommuniqué de presse : Sanofi entame un nouveau chapitre de..
10/22/202314:00GLOBEPress Release: Dupixent® (dupilumab) Phase 3 Results show..
10/19/202305:00GLOBECommuniqué de presse : Sanofi livre les premiers médicaments..
10/18/202303:45GLOBEPress Release: TZIELD® Phase 3 data presented at ISPAD shows..
10/17/202313:18GLOBESanofi: Information concerning the total number of voting..
10/13/202309:00GLOBEPress Release: Late-breaking amlitelimab Phase 2b data..
10/04/202300:00GLOBEPress Release: Sanofi and Teva announce exclusive..
10/03/202300:30GLOBEPress Release: Sanofi announces agreement for potential..
9/26/202300:30GLOBECommuniqué de presse : La FDA accorde un examen prioritaire..
9/25/202302:00GLOBEPress Release: Once-weekly ALTUVIIIO® approved in Japan as a..
9/22/202300:30GLOBEPress Release: Availability of the Q3 2023 Memorandum for..
9/19/202301:30GLOBECommuniqué de presse : Sanofi soutient les communautés..
9/11/202313:02GLOBESanofi: Information concerning the total number of voting..
8/31/202300:30GLOBEPress Release: Sanofi announces changes to its Executive..
8/15/202314:24GLOBESanofi: Information concerning the total number of voting..
8/03/202314:21GLOBEPress Release: U.S. CDC Advisory Committee unanimously..

Your Recent History

Delayed Upgrade Clock